We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.74B
AUM Growth
-$335M
Cap. Flow
-$614M
Cap. Flow %
-16.42%
Top 10 Hldgs %
21.69%
Holding
674
New
53
Increased
215
Reduced
238
Closed
121

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$107M
2
AAPL icon
Apple
AAPL
+$71.8M
3
TRV icon
Travelers Companies
TRV
+$27.6M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$27.4M
5
AXP icon
American Express
AXP
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.7%
2 Financials 10.88%
3 Technology 9.76%
4 Communication Services 9.34%
5 Consumer Staples 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ILMN icon
51
Illumina
ILMN
$29.4B
$17.1M 0.46%
91,774
+4,489
+5% +$724K
OXY icon
52
Occidental Petroleum
OXY
$57B
$17.1M 0.46%
252,702
+12,593
+5% +$906K
UNP icon
53
Union Pacific
UNP
$183B
$17M 0.45%
217,384
+170,156
+360% +$14.6M
HD icon
54
Home Depot
HD
$332B
$16.5M 0.44%
125,064
-110,059
-47% -$14M
BMY icon
55
Bristol-Myers Squibb
BMY
$127B
$16.3M 0.44%
237,464
+60,934
+35% +$4.03M
PH icon
56
Parker-Hannifin
PH
$125B
$16.3M 0.44%
168,332
-72,715
-30% -$7.37M
PEG icon
57
Public Service Enterprise Group
PEG
$39.8B
$16.3M 0.44%
421,438
-142,609
-25% -$5.72M
MDVN
58
DELISTED
MEDIVATION, INC.
MDVN
$16M 0.43%
330,000
-10,000
-3% -$431K
ED icon
59
Consolidated Edison
ED
$41.6B
$14.9M 0.4%
232,201
+219,503
+1,729% +$14.1M
CVS icon
60
CVS Health
CVS
$137B
$14.9M 0.4%
152,336
+24,800
+19% +$2.43M
AAL icon
61
American Airlines Group
AAL
$9.58B
$14.8M 0.4%
349,031
+213,633
+158% +$9.26M
SWK icon
62
Stanley Black & Decker
SWK
$14.2B
$14.6M 0.39%
137,185
+12,961
+10% +$1.37M
DHR icon
63
Danaher
DHR
$135B
$14.3M 0.38%
229,208
+178,430
+351% +$11.2M
UNH icon
64
UnitedHealth
UNH
$382B
$14.3M 0.38%
121,562
+19,829
+19% +$2.32M
CMS icon
65
CMS Energy
CMS
$23.1B
$14.1M 0.38%
392,078
+333,822
+573% +$11.9M
LLY icon
66
Eli Lilly
LLY
$1.07T
$14.1M 0.38%
167,419
-7,736
-4% -$642K
FLR icon
67
Fluor
FLR
$7.29B
$14M 0.38%
297,274
+178,471
+150% +$8.4M
HCA icon
68
HCA Healthcare
HCA
$84.8B
$13.9M 0.37%
205,975
+25,251
+14% +$1.76M
CMA
69
DELISTED
Comerica
CMA
$13.8M 0.37%
330,133
-141,675
-30% -$6.19M
LM
70
DELISTED
Legg Mason, Inc.
LM
$13.8M 0.37%
351,377
+105,029
+43% +$4.5M
COF icon
71
Capital One
COF
$124B
$13.5M 0.36%
186,758
+161,917
+652% +$12.4M
DIS icon
72
Walt Disney
DIS
$165B
$13.4M 0.36%
127,201
-41,967
-25% -$4.68M
CM icon
73
Canadian Imperial Bank of Commerce
CM
$107B
$13.3M 0.36%
404,250
-100
-0% -$3.67K
SE
74
DELISTED
Spectra Energy Corp Wi
SE
$13.1M 0.35%
549,047
+150,015
+38% +$3.99M
EMR icon
75
Emerson Electric
EMR
$82.9B
$13.1M 0.35%
274,243
-18,339
-6% -$873K

Similar funds

Candriam SCA's Q4 2015 Portfolio in Review

As of Q4 2015, Candriam SCA held 674 positions worth $3.74B, down 8.2% from $4.07B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA withdrew a net $614M in Q4 2015, closing 121 positions and reducing 238 holdings. Its most notable exit was Amgen, an estimated $107M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Alphabet (Google) Class A worth $118M.

  • Candriam SCA's largest Q4 2015 buy was Alphabet (Google) Class A: 3,043,280 shares worth $118M.
  • Candriam SCA added most to Intel in Q4 2015, an estimated $61.2M increase.
  • Candriam SCA's biggest Q4 2015 reduction was Colgate-Palmolive, cutting an estimated $21.3M.
  • Candriam SCA fully exited Amgen in Q4 2015, selling an estimated $107M.
  • Candriam SCA's ten largest holdings make up 22% of its $3.74B portfolio in Q4 2015.
  • Candriam SCA opened 53 new positions and closed 121 in Q4 2015.
  • Candriam SCA's portfolio value fell 8.2% quarter-over-quarter to $3.74B.

Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.